CHARACTERIZING SPATIO-TEMPORAL CHANGES IN IMMUNE CELL LANDSCAPES OF MULTIPLE SCLEROSIS PATIENTS IN RESPONSE TO B CELL DEPLETION WITH OCRELIZUMAB